[NSAID administration and esophageal pathology: interaction with gastroesophageal reflux disease (GERD) symptoms, risk factors and incidence of erosive esophagitis].
Karateev
A E
AE
Uspenskiĭ
Iu P
IuP
Pakhomova
I G
IG
Nasonov
E L
EL
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects*; D003627:Data Interpretation, Statistical; D016145:Endoscopy, Digestive System; D004941:Esophagitis / Q000139:chemically induced* / Q000453:epidemiology / Q000473:pathology; D005260:Female; D005764:Gastroesophageal Reflux / Q000139:chemically induced* / Q000453:epidemiology / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D011795:Surveys and Questionnaires
D000894:Anti-Inflammatory Agents, Non-Steroidal